These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25303554)

  • 1. Glucose control in critically ill patients in 2009: no alarms and no surprises.
    Pitrowsky M; Shinotsuka CR; Soares M; Salluh JI
    Rev Bras Ter Intensiva; 2009 Aug; 21(3):310-4. PubMed ID: 25303554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glycaemia control in critically ill patients is justified and effective].
    Rybka J
    Vnitr Lek; 2010 Sep; 56(9 Suppl):977-87. PubMed ID: 21137171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing hyperglycemia from hospital admission to discharge.
    Moghissi ES
    Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin treatment in intensive care patients.
    Derde S; Vanhorebeek I; Van den Berghe G
    Horm Res; 2009 Jan; 71(1):2-11. PubMed ID: 19039231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting tight glycemic control in perioperative and critically ill patients: when one size may not fit all.
    Abdelmalak BB; Lansang MC
    J Clin Anesth; 2013 Sep; 25(6):499-507. PubMed ID: 24008187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients.
    Jacobi J; Bircher N; Krinsley J; Agus M; Braithwaite SS; Deutschman C; Freire AX; Geehan D; Kohl B; Nasraway SA; Rigby M; Sands K; Schallom L; Taylor B; Umpierrez G; Mazuski J; Schunemann H
    Crit Care Med; 2012 Dec; 40(12):3251-76. PubMed ID: 23164767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The place for glycemic control in the surgical patient.
    May AK; Kauffmann RM; Collier BR
    Surg Infect (Larchmt); 2011 Oct; 12(5):405-18. PubMed ID: 22004441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective operationalization and feasibility of a glycemic control protocol in critically ill children.
    Branco RG; Xavier L; Garcia PC; Piva JP; Fiori HH; Baldisserotto M; Fiori RM; Tasker RC
    Pediatr Crit Care Med; 2011 May; 12(3):265-70. PubMed ID: 20935589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice of strict glycemic control in critically ill patients.
    Schultz MJ; de Graaff MJ; Royakkers AA; van Braam Houckgeest F; van der Sluijs JP; Kieft H; Spronk PE
    Med Sci Monit; 2008 Nov; 14(11):RA191-7. PubMed ID: 18971884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous glucagon-like peptide-1 for hyperglycemia in critically ill patients.
    Pinelli NR; Jones MC; Monday LM; Smith Z; Rhoney DH
    Ann Pharmacother; 2012 Jan; 46(1):124-9. PubMed ID: 22202493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of published scientific evidence on glycemic control in adult intensive care units.
    Niven DJ; Rubenfeld GD; Kramer AA; Stelfox HT
    JAMA Intern Med; 2015 May; 175(5):801-9. PubMed ID: 25775163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with tight glucose control by intensive insulin therapy.
    Preiser JC; Devos P
    Crit Care Med; 2007 Sep; 35(9 Suppl):S503-7. PubMed ID: 17713400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive insulin therapy for critically ill patients.
    Lewis KS; Kane-Gill SL; Bobek MB; Dasta JF
    Ann Pharmacother; 2004; 38(7-8):1243-51. PubMed ID: 15187219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials.
    Ling Y; Li X; Gao X
    Eur J Intern Med; 2012 Sep; 23(6):564-74. PubMed ID: 22863436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
    Van den Berghe G; Wouters PJ; Bouillon R; Weekers F; Verwaest C; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P
    Crit Care Med; 2003 Feb; 31(2):359-66. PubMed ID: 12576937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Software-guided insulin dosing: tight glycemic control and decreased glycemic derangements in critically ill patients.
    Saur NM; Kongable GL; Holewinski S; O'Brien K; Nasraway SA
    Mayo Clin Proc; 2013 Sep; 88(9):920-9. PubMed ID: 24001484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protocolized approach to identify and manage hyperglycemia in a pediatric critical care unit.
    Preissig CM; Hansen I; Roerig PL; Rigby MR
    Pediatr Crit Care Med; 2008 Nov; 9(6):581-8. PubMed ID: 18838924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hyperglycemia in the pediatric intensive care unit; implementation of a glucose control protocol.
    Verhoeven JJ; Brand JB; van de Polder MM; Joosten KF
    Pediatr Crit Care Med; 2009 Nov; 10(6):648-52. PubMed ID: 19602994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus recommendations for the management of hyperglycaemia in critically ill patients in the Indian setting.
    Mukherjee JJ; Chatterjee PS; Saikia M; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):16-25. PubMed ID: 25668933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.